Christoph Merten (born 1976) is a German bio-engineer and entrepreneur; currently professor at EPFL (École Polytechnique Fédérale de Lausanne).

[3] In 2005, he started a second postdoctoral appointment at the Institut de science et d'ingénierie supramoléculaires (ISIS) in Strasbourg, France.

From 2010 to 2019, he served as a group leader at the European Molecular Biology Laboratory in Heidelberg, where he established high-throughput droplet-based microfluidic screening platforms.

[5] In 2019, he was named associate professor of bioengineering at EPFL[6] and currently leads the laboratory for biomedical microfluidics (LBMM) within the School of Engineering.

[9] His laboratory currently uses droplet-based approaches to address questions related to personalized medicine, biological screening assays, and genomics.